Compacted Hemostatic Cellulosic Aggregates
US-2024173457-A1 · May 30, 2024 · US
US10357590B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10357590-B2 |
| Application number | US-201615342393-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 3, 2016 |
| Priority date | Sep 6, 2012 |
| Publication date | Jul 23, 2019 |
| Grant date | Jul 23, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure is directed to a bioresorbable ceramic composition having a plurality of biocompatible ceramic granules, each of the granules having a coating of a plurality of calcium containing particles, where at least a portion of the particles are bound to at least a portion of an outer surface of each of the granules, and further where the composition is flowable in a dry state. The present disclosure is also directed to a three dimensional scaffold for bone repair that includes the bioresorbable composition, which upon implantation to a locus of repair defines an interconnected pore network between outer walls of the coated granules of the composition. Finally, the present disclosure is directed to methods of forming both the bioresorbable ceramic composition and the three-dimensional ceramic scaffold.
Opening claim text (preview).
The invention claimed is: 1. A process for manufacturing a biocompatible ceramic composition comprising: (a) reacting a mixture of calcium containing particles and β-tricalcium phosphate (β-TCP) granules with an aqueous medium resulting in a coating of the calcium-containing particles on at least a portion of an out surface of the β-TCP granules, the coating being bound to the outer surface so as to form a plurality of coated granules through chemical reactions that can be further accelerated by autoclaving; and (b) dehydrating the coated granules by lyophilization; wherein the calcium-containing particles are a mixture of α-TCP, monocalcium phosphate monohydrate (MCPM), and calcite, or a mixture of calcium sulfate hemihydrate, α-TCP, MCPM, and calcite; and wherein the plurality of biocompatible granules is β-TCP; and wherein the coated granules have a weight ratio range between the weight of the granules and the particles of about 90:10 to about 40:60. 2. The process of claim 1 , wherein the step of dehydrating at least partially dehydrates the coated granules to remove excess unbound water. 3. The process of claim 1 , wherein the step of dehydrating includes controlling reactivity of at least a portion of the coating such that the portion is a reactive portion that is reactive to subsequent hydraulic reactions. 4. The process according to claim 1 further comprising: forming at least one additional coating on the coated granules. 5. The process according to claim 4 , wherein the step of forming at least one additional coating is forming at least two additional coatings on the coated granules. 6. The process according to claim 4 , wherein the step of forming the additional coating is prior to the step of dehydrating. 7. The process according to claim 4 , wherein the step of forming the additional coating is after the step of dehydrating.
Applying particulate materials (B05D1/06, B05D1/10 take precedence) · CPC title
Coatings comprising two or more layers · CPC title
Porous materials, {e.g. foams or sponges} · CPC title
for reconstruction of bones; weight-bearing implants · CPC title
Methods for coating medical devices · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.